These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 111889)

  • 1. The antipyrine test in clinical pharmacology: conceptions and misconceptions.
    Vesell ES
    Clin Pharmacol Ther; 1979 Sep; 26(3):275-86. PubMed ID: 111889
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of environmental agents and drugs.
    Burns JJ
    Environ Res; 1969 Oct; 2(5):352-9. PubMed ID: 4985962
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vivo activity of drug-metabolizing enzymes in various pathological conditions].
    Krakovskiĭ ME; Ashirmetov AKh
    Vopr Med Khim; 1985; 31(1):76-9. PubMed ID: 3984279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer and nutrition (review).
    McLean AE
    Nahrung; 1976; 20(4):339-42. PubMed ID: 781541
    [No Abstract]   [Full Text] [Related]  

  • 5. Impairment of hepatic drug metabolism in patients with acute viral hepatitis.
    Narang AP; Datta DV; Nath N; Mathur VS
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):255-8. PubMed ID: 7166177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipyrine half-life and drug elimination.
    Breckenridge A
    Clin Pharmacokinet; 1980; 5(3):201-3. PubMed ID: 7389234
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug metabolism.
    McEwen J; Stevenson IH
    Scott Med J; 1972 Feb; 17(2):67-77. PubMed ID: 4622974
    [No Abstract]   [Full Text] [Related]  

  • 8. A new polymorphism of hepatic drug oxidation in man: family studies on rates of formation of antipyrine metabolites.
    Vessell ES; Penno MB
    Biochem Soc Trans; 1984 Feb; 12(1):74-8. PubMed ID: 6705993
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of drug metabolism by hydroxylated metabolites: cross-inhibition and specificity.
    Soda DM; Levy G
    J Pharm Sci; 1975 Dec; 64(12):1928-31. PubMed ID: 1206483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of nifedipine on hepatic drug oxidation.
    Dickinson TH; Egan JM; Abernethy DR
    Pharmacology; 1988; 36(6):405-10. PubMed ID: 3420161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An introduction to principles of veterinary clinical pharmacology: the elimination of drugs. 1. Rate of drug elimination.
    Baggot JD
    N Z Vet J; 1974 Mar; 22(3):31-7. PubMed ID: 4209566
    [No Abstract]   [Full Text] [Related]  

  • 12. How potent is the inhibition of drug metabolism by omeprazole?
    Webster LK; Jones DB; Smallwood RA
    Lancet; 1984 Sep; 2(8405):761. PubMed ID: 6148515
    [No Abstract]   [Full Text] [Related]  

  • 13. Ascorbic acid and drug metabolism in cynomologus monkeys.
    Green M; Turnbull J; Sauberlich H; Omaye S
    Proc West Pharmacol Soc; 1978; 21():341-4. PubMed ID: 99749
    [No Abstract]   [Full Text] [Related]  

  • 14. Individual differences in the disposition of drugs metabolised in the body.
    Alvan G
    Clin Pharmacokinet; 1978; 3(2):155-75. PubMed ID: 346288
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug metabolism in rats bearing a pituitary mammotropic tumor.
    Villeneuve JP; Gerber JG; Branch RA; Shand DG; Wilson JT
    J Pharmacol Exp Ther; 1979 Apr; 209(1):7-11. PubMed ID: 430380
    [No Abstract]   [Full Text] [Related]  

  • 16. Interindividual differences in pharmacokinetics in man: clinical importance.
    Sjöqvist F
    Panminerva Med; 1973 Apr; 15(4):99-112. PubMed ID: 4808047
    [No Abstract]   [Full Text] [Related]  

  • 17. Salicylate metabolism in man.
    Davison C
    Ann N Y Acad Sci; 1971 Jul; 179():249-68. PubMed ID: 4998910
    [No Abstract]   [Full Text] [Related]  

  • 18. Impaired oxidation of antipyrine in stagnant loop rats.
    Aarbakke J
    Scand J Gastroenterol; 1977; 12(8):929-35. PubMed ID: 605352
    [No Abstract]   [Full Text] [Related]  

  • 19. Impairment of drug elimination in patients with liver disease.
    Narang AP; Datta DV; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1985 Jan; 23(1):28-32. PubMed ID: 3988389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of combined pre-treatment on the metabolism of antipyrine in the rat.
    Szabó I; Renczes G; Gachályi B
    Acta Physiol Hung; 1995; 83(1):51-3. PubMed ID: 7660837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.